MétaCan
Menu
Back to cohort

Abstract B235: The role of eIF4E in promoting melanoma cell proliferation and maintaining acquired resistance to vemurafenib in melanoma.

2013· article· en· W2058563691 on OpenAlexaff
Michael S. Dahabieh, Sonia V. del Rincón, Wilson H. Miller

Bibliographic record

VenueMolecular Cancer Therapeutics · 2013
Typearticle
Languageen
FieldMedicine
TopicAutophagy in Disease and Therapy
Canadian institutionsJewish General HospitalMontreal General HospitalMcGill University
Fundersnot available
KeywordsVemurafenibMelanomaCancer researchCell growthGene silencingCell cultureEIF4EBiologyAutophagyCarcinogenesisCancerApoptosisTranslation (biology)Messenger RNAGeneticsGene

Abstract

fetched live from OpenAlex

Abstract In eukaryotic cells, mRNA translation is restricted by the translation initiation step, in which eIF4E has been regarded as a master regulator. Overexpression of eIF4E has been found in different cancer types; however, whether eIF4E is involved in melanoma tumorigenesis and resistance to standard of care in melanoma remains unclear. We hypothesize that eIF4E promotes melanoma cell proliferation and facilitates the development of acquired resistance to the B-raf inhibitor, Vemurafenib. From our preliminary data, we show that by genetically knocking down eIF4E via siRNA or by using a pharmacological inhibitor of eIF4E, 4EGI-1, we can significantly repress the proliferation of a subset of melanoma cell lines. In addition, eIF4E activity contributes to the proliferation of some melanoma cell lines with acquired resistance to Vemurafenib, since siRNA-silencing eIF4E decreases their proliferation. Similarly, 4EGI-1 seems to be more effective at inhibiting cell proliferation of Vemurafenib resistant lines compared to their parental controls. Finally, we found that autophagy may act as a pro-survival mechanism in melanoma cell lines, based on the observation that the autophagy inhibitors Chloroquine, Bafilomycin, and 3-MA can repress cell proliferation in both BRAF V600E and BRAF WT cell lines. Further investigation with qPCR and western blot showed that eIF4E expression can be significantly downregulated at the mRNA and protein levels with inhibition of autophagy. This implies a role for eIF4E in mediating the pro-survival autophagy pathway in melanoma. Moreover, the expression of key autophagy markers, such as Atg5 and LC-3 II have been upregulated in several Vemurafenib resistant cell lines compared to the parental A375. In conclusion, our data show that eIF4E promotes proliferation of some melanoma cell lines. We also show that eIF4E is involved in maintaining the survival of some melanoma cell lines with acquired vemurafenib resistance. These data suggest that therapeutically targeting eIF4E, and disrupting pro-survival autophagy, may be a viable means of inhibiting melanoma cell proliferation and overcoming vemurafenib resistance. Citation Information: Mol Cancer Ther 2013;12(11 Suppl):B235. Citation Format: Yao Zhan, Michael S. Dahabieh, Sonia V. del Rincon, Wilson H. Miller, Jr.. The role of eIF4E in promoting melanoma cell proliferation and maintaining acquired resistance to vemurafenib in melanoma. [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; 2013 Oct 19-23; Boston, MA. Philadelphia (PA): AACR; Mol Cancer Ther 2013;12(11 Suppl):Abstract nr B235.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.240
Threshold uncertainty score0.500

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.011
GPT teacher head0.265
Teacher spread0.253 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2013
Admission routes1
Has abstractyes

Explore more

Same venueMolecular Cancer TherapeuticsSame topicAutophagy in Disease and TherapyFrench-language works237,207